Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 49
CAR-NK cells for cancer immunotherapy: recent advances and future directions
Tianye Li, Mengke Niu, Weijiang Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 22
Hallmarks of cancer resistance
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 18
The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling
Tianye Li, Mengke Niu, Jianwei Zhou, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment
Haixia Zhang, Shizhen Li, Dan Wang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 14
The interaction of innate immune and adaptive immune system
Ruyuan Wang, Caini Lan, Kamel Benlagha, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 14
Autophagy in cancer immunotherapy: Perspective on immune evasion and cell death interactions
Qiang Yu, Jiajun Ding, Shisen Li, et al.
Cancer Letters (2024) Vol. 590, pp. 216856-216856
Closed Access | Times Cited: 9
Cell cycle‐based antibody selection for suppressing cancer cell growth
Chi Hun Song, Chih‐Wei Lin, Kyung Ho Han
The FASEB Journal (2025) Vol. 39, Iss. 4
Open Access | Times Cited: 1
Oncometabolite 2-hydroxyglutarate regulates anti-tumor immunity
Mengyuan Cai, Jianyi Zhao, Qiang Ding, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24454-e24454
Open Access | Times Cited: 7
Beyond success: unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors
Yuze Wu, Ming Yi, Mengke Niu, et al.
Cancer Communications (2024) Vol. 44, Iss. 7, pp. 739-760
Open Access | Times Cited: 7
Innate Immune Cells in Tumour Microenvironment: A New Frontier in Cancer Immunotherapy
Changhui Li, Xinyu Yu, Xinyan Han, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110750-110750
Open Access | Times Cited: 7
SHISA3 Reprograms Tumor‐Associated Macrophages Toward an Antitumoral Phenotype and Enhances Cancer Immunotherapy
Shimeng Zhang, Bingbing Yu, Chunjie Sheng, et al.
Advanced Science (2024)
Open Access | Times Cited: 6
Exploring the Immunological Profile in Breast Cancer: Recent Advances in Diagnosis and Prognosis through Circulating Tumor Cells
Amalia Kotsifaki, Sousanna Maroulaki, Athanasios Armakolas
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4832-4832
Open Access | Times Cited: 5
Immunotherapy in liver cancer: overcoming the tolerogenic liver microenvironment
Yanju Liu, Hongyuan Yang, Tian Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Targeting immune checkpoints on myeloid cells: current status and future directions
Chuhan Ma, Yang Li, Min Li, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 2
Open Access
Editorial: Enhancing innate immunity in combination therapy for solid tumors
David Pejoski
Frontiers in Immunology (2025) Vol. 15
Open Access
Modifying metabolic and immune hallmarks of cancer by a copper complex
Chengyan Chu, Yunhua Zhang, Chengyuan Qian, et al.
Science China Chemistry (2025)
Closed Access
An Injectable Gambogic Acid Loaded Nanocomposite Hydrogel Enhances Antitumor Effect by Reshaping Immunosuppressive Tumor Microenvironment
Dan Lei, Wanru Wang, Jianhang Zhao, et al.
(2025)
Closed Access
m5C methylation modification may be an accomplice in colorectal cancer escaping from anti-tumor effects of innate immunity-type I/III interferon
Yiqi Sun, Yunfei Liu, Lu Jiang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Therapeutic role of immune cells against colon cancer
Manoj Kumar Gupta, Gayatri Gouda, Ramakrishna Vadde
Elsevier eBooks (2025), pp. 127-146
Closed Access
Chemotherapy boosts anti-angiogenic and anti-PD-1 combination therapy through activation of cCAS-STING pathway in colon cancer
Xiaofei Li, Yu-Wen Dong, Tingyu Wang, et al.
International Immunopharmacology (2025) Vol. 149, pp. 114212-114212
Closed Access
Recent advances in nanomedicine therapy for bacterial pneumonia
Weiqian Jin, Ling Liao, Tao Qin, et al.
Chinese Chemical Letters (2025), pp. 110920-110920
Closed Access
A Dual Stimuli-Responsive Nanoimmunomodulator for Antitumor Synergy of Macrophages and T Cells
Jun‐Ying Ding, Xueze Zhao, Saran Long, et al.
ACS Nano (2025)
Closed Access
Drug delivery for platinum therapeutics
Hui Liu, Jiahui Zou, Xiaotong Li, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 503-523
Closed Access
Decoding immune tolerance in infertility: Exploring immune pathways and non-coding RNAs as pioneering biomarkers and therapeutic targets
Harikumar Pallathadka, Abdulrahman Qais Khaleel, Ahmed Hjazi, et al.
Human Immunology (2025) Vol. 86, Iss. 3, pp. 111264-111264
Closed Access
Page 1 - Next Page

Scroll to top